Literature DB >> 1866153

Partial lamellar sclerouvectomy for ciliary body and choroidal tumors.

J A Shields1, C L Shields, P Shah, V Sivalingam.   

Abstract

The authors reviewed the postoperative course, visual results, histopathologic findings, and mortality data on 95 consecutive patients with tumors of the ciliary body and/or choroid who were managed by a partial lamellar sclerouvectomy. This surgical procedure is designed to remove the uveal tumor and leave intact the outer sclera and sensory retina. In this group of 95 patients, vitreous hemorrhage occurred in 79 (83%) cases, intraretinal or subretinal hemorrhage in 33 (35%), retinal detachment in 26 (28%), and cataract in 32 (34%). Most of the vitreous and retinal hemorrhages resolved spontaneously, sometimes leaving subretinal or preretinal fibrosis. A number of the postoperative retinal detachments resolved spontaneously, but retinal detachment surgery was necessary in 16 patients (17%), mostly in the earlier years of the survey. Most of the cataracts were mild and did not require surgery. The eventual postoperative visual acuity was equal to or better than the preoperative visual acuity in 23 cases (24%) over a mean follow-up period of 5 years. Enucleation was eventually necessary in 15 cases (16%), usually because of residual or recurrent tumor. Histopathologic diagnosis was uveal melanoma in 81 cases (85%) and other tumors in 14 cases (15%). There were no orbital recurrences, but distant metastases developed in five patients (5%), all of whom had undergone enucleation for recurrence of the intraocular melanoma. Although the surgical technique is difficult, partial lamellar sclerouvectomy appears to be a reasonable therapeutic option in selected cases of posterior uveal tumors.

Entities:  

Mesh:

Year:  1991        PMID: 1866153     DOI: 10.1016/s0161-6420(91)32194-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  30 in total

1.  Local resection of posterior uveal melanoma.

Authors:  J A Shields
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

2.  Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

3.  Indications for trans-scleral local resection of uveal melanoma.

Authors:  B Damato; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

4.  Local resection of choroidal melanoma.

Authors:  I Rennie
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

5.  Eye-wall resection.

Authors:  D H Char; T Miller; J B Crawford
Journal:  Trans Am Ophthalmol Soc       Date:  2000

6.  Risk factors for metastatic uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

7.  Exoresection via partial lamellar sclerouvectomy approach for uveal tumors: A successful performance by a novice surgeon.

Authors:  Rengin Aslihan Kurt; Kaan Gündüz
Journal:  Clin Ophthalmol       Date:  2010-02-02

8.  Exoresection and endoresection for uveal melanoma.

Authors:  Kaan Gündüz; Nikolaos E Bechrakis
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

9.  Predictive factors of visual outcome after local resection of choroidal melanoma.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

10.  Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival.

Authors:  P De Potter; C L Shields; J A Shields; J R Cater; D J Tardio
Journal:  Br J Ophthalmol       Date:  1994-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.